PET imaging in patients with brain metastasis-report of the RANO/PET group.

Animals Brain Neoplasms / diagnostic imaging Humans Molecular Imaging / methods Positron-Emission Tomography / methods Radiopharmaceuticals / metabolism
FDG PET FET amino acid PET brain metastases pseudoprogression

Journal

Neuro-oncology
ISSN: 1523-5866
Titre abrégé: Neuro Oncol
Pays: England
ID NLM: 100887420

Informations de publication

Date de publication:
06 05 2019
Historique:
received: 08 09 2018
revised: 11 10 2018
accepted: 03 01 2019
pubmed: 8 1 2019
medline: 20 8 2020
entrez: 8 1 2019
Statut: ppublish

Résumé

Brain metastases (BM) from extracranial cancer are associated with significant morbidity and mortality. Effective local treatment options are stereotactic radiotherapy, including radiosurgery or fractionated external beam radiotherapy, and surgical resection. The use of systemic treatment for intracranial disease control also is improving. BM diagnosis, treatment planning, and follow-up is most often based on contrast-enhanced magnetic resonance imaging (MRI). However, anatomic imaging modalities including standard MRI have limitations in accurately characterizing posttherapeutic reactive changes and treatment response. Molecular imaging techniques such as positron emission tomography (PET) characterize specific metabolic and cellular features of metastases, potentially providing clinically relevant information supplementing anatomic MRI. Here, the Response Assessment in Neuro-Oncology working group provides recommendations for the use of PET imaging in the clinical management of patients with BM based on evidence from studies validated by histology and/or clinical outcome.

Identifiants

DOI: 10.1093/neuonc/noz003 PMID: 30615138 PMC: PMC6502495
pubmed: 30615138
pii: 5274178
doi: 10.1093/neuonc/noz003
pmc: PMC6502495
doi:

Substances chimiques

Radiopharmaceuticals 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

585-595

Subventions

Organisme : NCI NIH HHS
ID : P50 CA211015
Pays : United States

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Neuro Oncol. 2016 Jul;18(7):1021-7
pubmed: 26865086
Radiat Oncol. 2011 May 15;6:48
pubmed: 21575163
Eur J Nucl Med Mol Imaging. 2018 Nov;45(12):2245
pubmed: 30167802
Eur J Nucl Med Mol Imaging. 2007 Dec;34(12):2082-7
pubmed: 17763978
PLoS One. 2015 Jul 13;10(7):e0132515
pubmed: 26167681
J Neurooncol. 2013 Jan;111(1):11-8
pubmed: 23086431
J Nucl Med. 2014 Jan;55(1):30-6
pubmed: 24167081
Nucl Med Commun. 2017 Dec;38(12):1109-1116
pubmed: 28922334
Lancet Oncol. 2015 Nov;16(15):e534-e542
pubmed: 26545842
Handb Clin Neurol. 2018;149:113-121
pubmed: 29307348
Neuro Oncol. 2017 Feb 1;19(2):281-288
pubmed: 27471107
Breast Cancer Res Treat. 2016 Nov;160(1):51-59
pubmed: 27620882
J Nucl Med. 2013 Jul;54(7):1007-10
pubmed: 23708197
Neuroimage Clin. 2016 Dec 18;13:386-394
pubmed: 28116231
Handb Clin Neurol. 2018;149:89-112
pubmed: 29307364
Br J Cancer. 2008 Feb 26;98(4):742-8
pubmed: 18253116
Expert Rev Anticancer Ther. 2017 May;17(5):395-397
pubmed: 28277832
J Med Imaging Radiat Oncol. 2018 Jun;62(3):383-388
pubmed: 29745036
J Nucl Med. 2015 Jan;56(1):9-15
pubmed: 25537990
Mol Imaging. 2013 Jul-Aug;12(5):327-37
pubmed: 23759373
Eur J Nucl Med Mol Imaging. 2012 Aug;39(8):1284-8
pubmed: 22526964
Strahlenther Onkol. 2017 Oct;193(10):767-779
pubmed: 28687979
Clin Nucl Med. 2017 Mar;42(3):193-194
pubmed: 28033225
Neuro Oncol. 2017 Feb 1;19(2):162-174
pubmed: 28391295
Eur J Nucl Med Mol Imaging. 2015 Apr;42(5):685-95
pubmed: 25411133
Eur Radiol. 2017 Jul;27(7):2916-2927
pubmed: 27853813
J Thorac Oncol. 2015 Aug;10(8):e67-8
pubmed: 26200280
Clin Cancer Res. 2016 Dec 1;22(23):5765-5771
pubmed: 27803067
Br J Cancer. 2017 Jun 6;116(12):1558-1563
pubmed: 28524161
Eur J Nucl Med Mol Imaging. 2015 Jan;42(1):103-11
pubmed: 25182751
Neuro Oncol. 2016 Sep;18(9):1199-208
pubmed: 27106405
Neuro Oncol. 2017 Mar 1;19(3):454-456
pubmed: 28039369
Semin Nucl Med. 2012 Nov;42(6):356-70
pubmed: 23026359
Eur J Nucl Med Mol Imaging. 2014 Feb;41(2):397-8
pubmed: 24081449
J Nucl Med. 2012 Aug;53(8):1253-61
pubmed: 22743251
Handb Clin Neurol. 2018;149:123-127
pubmed: 29307349
Neuro Oncol. 2015 May;17(5):757-63
pubmed: 25537018
Neuro Oncol. 2016 Oct;18(10):1462-4
pubmed: 27591333
J Neurooncol. 2010 Sep;99(2):217-25
pubmed: 20091333
Clin Nucl Med. 2015 Jun;40(6):494-5
pubmed: 25674864
Oncotarget. 2018 May 22;9(39):25597-25616
pubmed: 29876011
Nucl Med Biol. 2006 Apr;33(3):287-94
pubmed: 16631076
Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):1049-58
pubmed: 21570201
PLoS One. 2016 Jun 08;11(6):e0157139
pubmed: 27276226
Oncotarget. 2017 May 30;8(22):35743-35749
pubmed: 28415747
Neuro Oncol. 2017 Nov 29;19(12):1576-1587
pubmed: 28605532
Curr Opin Neurol. 2018 Aug;31(4):354-361
pubmed: 29952832
Clin Nucl Med. 2011 Oct;36(10):841-7
pubmed: 21892031
Neuroimage Clin. 2018 Aug 19;20:537-542
pubmed: 30175040
Sci Rep. 2018 Jun 13;8(1):9043
pubmed: 29899472
Nucl Med Rev Cent East Eur. 2015;18(1):39-41
pubmed: 25633517
Nucl Med Biol. 2003 Jul;30(5):501-8
pubmed: 12831987
Minim Invasive Neurosurg. 2005 Aug;48(4):228-34
pubmed: 16172969
AJNR Am J Neuroradiol. 2017 Aug;38(8):1520-1527
pubmed: 28619837
J Nucl Med. 2012 Apr;53(4):552-8
pubmed: 22419752
Mol Cancer Ther. 2018 Aug;17(8):1625-1636
pubmed: 30068751
J Clin Pathol. 2012 Nov;65(11):1019-23
pubmed: 22813728
Handb Clin Neurol. 2018;149:27-42
pubmed: 29307358
J Nucl Med Technol. 2017 Sep;45(3):193-197
pubmed: 28705927
Lancet Oncol. 2018 Jan;19(1):e20-e32
pubmed: 29304358
J Comput Assist Tomogr. 1983 Dec;7(6):1062-6
pubmed: 6415134
Front Oncol. 2018 Feb 22;8:18
pubmed: 29520339
J Nucl Med. 2008 May;49(5):694-9
pubmed: 18413375
Eur J Nucl Med Mol Imaging. 2012 Jul;39(7):1089-96
pubmed: 22419257
Ann Nucl Med. 2018 Oct;32(8):512-522
pubmed: 30109562
BMC Cancer. 2017 Nov 6;17(1):713
pubmed: 29110648
AJNR Am J Neuroradiol. 2015 Dec;36(12):2250-5
pubmed: 26427832
J Nucl Med. 2014 Feb;55(2):275-80
pubmed: 24434290
Clin Nucl Med. 2018 Jul;43(7):518-519
pubmed: 29742608
J Neurosurg. 2003 May;98(5):1056-64
pubmed: 12744366
Clin Cancer Res. 2009 Dec 1;15(23):7412-20
pubmed: 19934295
Nucl Med Commun. 2013 Jun;34(6):540-3
pubmed: 23503001
Mol Imaging Biol. 2008 Jan-Feb;10(1):1-18
pubmed: 17957408
Clin Imaging. 2015 Nov-Dec;39(6):970-4
pubmed: 26259864
Neuro Oncol. 2016 Jun;18(6):873-80
pubmed: 26688076
Int J Cancer. 2001 Jun 20;96(3):191-7
pubmed: 11410888
J Nucl Med. 2013 Aug;54(8):1217-22
pubmed: 23785172
Neuro Oncol. 2016 Nov;18(11):1538-1547
pubmed: 27106404
Radiology. 2000 Nov;217(2):377-84
pubmed: 11058631
Lancet Oncol. 2015 Jun;16(6):e270-8
pubmed: 26065612
J Nucl Med. 2017 Apr;58(4):584-589
pubmed: 27754904
J Nucl Med. 2012 Sep;53(9):1367-74
pubmed: 22872742
Neuro Oncol. 2013 Aug;15(8):1058-67
pubmed: 23460322
Nuklearmedizin. 2011;50(3):101-6
pubmed: 21165538
Nat Rev Neurol. 2017 May;13(5):279-289
pubmed: 28387340
J Neurooncol. 2014 Dec;120(3):665-6
pubmed: 25151508
Neuro Oncol. 2015 Sep;17(9):1293-300
pubmed: 26008606
J Nucl Med. 2014 Feb;55(2):198-203
pubmed: 24379223
Ann Nucl Med. 2018 Oct;32(8):503-511
pubmed: 30105558
Mol Imaging. 2014;13:
pubmed: 24825818
J Neurooncol. 2011 May;103(1):137-46
pubmed: 20838854
BMC Clin Pathol. 2012 Feb 28;12:4
pubmed: 22373026
J Nucl Med. 1999 Jan;40(1):205-12
pubmed: 9935078
Mol Imaging Biol. 2018 Oct;20(5):683-695
pubmed: 30084044
Radiat Oncol. 2016 Oct 21;11(1):139
pubmed: 27769279
Eur J Nucl Med Mol Imaging. 2003 Nov;30(11):1561-7
pubmed: 14579097
Neuro Oncol. 2015 Nov;17(11):1434-44
pubmed: 26130743
Clin Nucl Med. 2015 Apr;40(4):328-9
pubmed: 25674861
Eur J Nucl Med. 2000 May;27(5):542-9
pubmed: 10853810
Eur J Nucl Med Mol Imaging. 2016 Jun;43(6):1105-14
pubmed: 26666239
Clin Nucl Med. 2016 Jul;41(7):564-5
pubmed: 27163462
Neuro Oncol. 2014 Mar;16(3):434-40
pubmed: 24305717
Nat Med. 1998 Nov;4(11):1334-6
pubmed: 9809561
Eur J Nucl Med Mol Imaging. 2003 Jan;30(1):96-100
pubmed: 12483415
Br J Radiol. 2018 Nov;91(1091):20180308
pubmed: 29762048
Nat Rev Neurol. 2015 Sep;11(9):504-14
pubmed: 26260659
Nat Rev Neurol. 2016 Jul;12(7):375-6
pubmed: 27282652
Handb Clin Neurol. 2018;149:137-153
pubmed: 29307351
J Neurooncol. 2013 Apr;112(2):141-52
pubmed: 23344789
Neuro Oncol. 2017 Sep 1;19(9):1271-1278
pubmed: 28204572

Auteurs

Norbert Galldiks (N)

Department of Neurology, University Hospital Cologne, Cologne, Germany.
Institute of Neuroscience and Medicine 3, 4, Research Center Juelich, Juelich, Germany.
Center of Integrated Oncology, Universities of Cologne and Bonn, Cologne, Germany.

Karl-Josef Langen (KJ)

Institute of Neuroscience and Medicine 3, 4, Research Center Juelich, Juelich, Germany.
Department of Nuclear Medicine, University Hospital Aachen, Aachen, Germany.

Nathalie L Albert (NL)

Department of Nuclear Medicine, Ludwig Maximilians-University of Munich, Munich, Germany.

Marc Chamberlain (M)

Departments of Neurology and Neurological Surgery, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington, USA.

Riccardo Soffietti (R)

Department of Neuro-Oncology, University and City of Health and Science Hospital, Turin, Italy.

Michelle M Kim (MM)

Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan, USA.

Ian Law (I)

Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, University of Copenhagen, Denmark.

Emilie Le Rhun (E)

Department of Neurosurgery, University Hospital Lille, Lille, France.

Susan Chang (S)

Department of Neurosurgery, University of California, San Francisco, California, USA.

Julian Schwarting (J)

Department of Neurosurgery, Ludwig Maximilians-University of Munich, Munich, Germany.
German Cancer Consortium, Partner Site Munich, Germany.

Stephanie E Combs (SE)

Department of Radiation Oncology, Technical University Munich, Munich, Germany.

Matthias Preusser (M)

Department of Medicine I and Comprehensive Cancer Centre CNS Tumours Unit, Medical University of Vienna, Vienna, Austria.

Peter Forsyth (P)

Moffitt Cancer Center, University of South Florida, Tampa, Florida, USA.

Whitney Pope (W)

Department of Radiological Sciences, David Geffen School of Medicine, University of California, Los Angeles, California , USA.

Michael Weller (M)

Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland.

Jörg C Tonn (JC)

Department of Neurosurgery, Ludwig Maximilians-University of Munich, Munich, Germany.
German Cancer Consortium, Partner Site Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › PET imaging in patients with brain...
questionsmedicales.fr › Maladies du système nerveux › Tumeurs du système nerveux › Tumeurs du système nerveux central › Tumeurs du cerveau › PET imaging in patients with brain...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › PET imaging in patients with brain...
questionsmedicales.fr › Techniques d'investigation › Techniques de sonde moléculaire › Imagerie moléculaire › PET imaging in patients with brain...
questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Techniques de diagnostic radioisotopique › Scintigraphie › Tomoscintigraphie › Tomographie par émission de positons › PET imaging in patients with brain...
questionsmedicales.fr › Actions chimiques et utilisations › Utilisations spécialisées de produits chimiques › Produits chimiques de laboratoire › Indicateurs et réactifs › Radiopharmaceutiques › PET imaging in patients with brain...